• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

MET 的蛋白水解切割:受体酪氨酸激酶的分而治之策略。

Proteolytic cleavages of MET: the divide-and-conquer strategy of a receptor tyrosine kinase.

机构信息

University of Lille, CNRS, Institut Pasteur de Lille, UMR 8161 - M3T - Mechanisms of Tumorigenesis and Target Therapies, F-59000 Lille, France.

出版信息

BMB Rep. 2019 Apr;52(4):239-249. doi: 10.5483/BMBRep.2019.52.4.024.

DOI:10.5483/BMBRep.2019.52.4.024
PMID:30670153
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6507848/
Abstract

Membrane-anchored full-length MET stimulated by its ligand HGF/SF induces various biological responses, including survival, growth, and invasion. This panel of responses, referred to invasive growth, is required for embryogenesis and tissue regeneration in adults. On the contrary, MET deregulation is associated with tumorigenesis in many kinds of cancer. In addition to its well-documented ligand-stimulated downstream signaling, the receptor can be cleaved by proteases such as secretases, caspases, and calpains. These cleavages are involved either in MET receptor inactivation or, more interestingly, in generating active fragments that can modify cell fate. For instance, MET fragments can promote cell death or invasion. Given a large number of proteases capable of cleaving MET, this receptor appears as a prototype of proteolytic-cleavage-regulated receptor tyrosine kinase. In this review, we describe and discuss the mechanisms and consequences, both physiological and pathological, of MET proteolytic cleavages. [BMB Reports 2019; 52(4): 239-249].

摘要

膜锚定全长 MET 受其配体 HGF/SF 的刺激,可诱导多种生物学反应,包括存活、生长和侵袭。这种反应被称为侵袭性生长,是胚胎发生和成人组织再生所必需的。相反,MET 失调与多种癌症的肿瘤发生有关。除了其有充分文献记载的配体刺激的下游信号外,受体还可以被蛋白酶如分泌酶、半胱天冬酶和钙蛋白酶切割。这些切割要么参与 MET 受体失活,要么更有趣的是,产生能够改变细胞命运的活性片段。例如,MET 片段可以促进细胞死亡或侵袭。鉴于能够切割 MET 的大量蛋白酶,这种受体似乎是蛋白水解切割调节的受体酪氨酸激酶的原型。在这篇综述中,我们描述并讨论了 MET 蛋白水解切割的机制和生理及病理后果。[BMB 报告 2019;52(4): 239-249]。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1bc/6507848/86e72d636c58/bmb-52-239f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1bc/6507848/f83a7447e064/bmb-52-239f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1bc/6507848/86e72d636c58/bmb-52-239f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1bc/6507848/f83a7447e064/bmb-52-239f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1bc/6507848/86e72d636c58/bmb-52-239f2.jpg

相似文献

1
Proteolytic cleavages of MET: the divide-and-conquer strategy of a receptor tyrosine kinase.MET 的蛋白水解切割:受体酪氨酸激酶的分而治之策略。
BMB Rep. 2019 Apr;52(4):239-249. doi: 10.5483/BMBRep.2019.52.4.024.
2
Necrosis- and apoptosis-related Met cleavages have divergent functional consequences.与坏死和凋亡相关的Met裂解具有不同的功能后果。
Cell Death Dis. 2015 May 21;6(5):e1769. doi: 10.1038/cddis.2015.132.
3
MET receptor variant R970C favors calpain-dependent generation of a fragment promoting epithelial cell scattering.MET受体变体R970C有利于钙蛋白酶依赖性地产生促进上皮细胞散射的片段。
Oncotarget. 2017 Feb 14;8(7):11268-11283. doi: 10.18632/oncotarget.14499.
4
Caspase cleavage of the MET receptor generates an HGF interfering fragment.MET受体的半胱天冬酶切割产生一种肝细胞生长因子干扰片段。
Biochem Biophys Res Commun. 2008 Mar 14;367(3):573-7. doi: 10.1016/j.bbrc.2007.12.177. Epub 2008 Jan 8.
5
Met degradation: more than one stone to shoot a receptor down.失活:一石二鸟,敲除受体。
FASEB J. 2012 Apr;26(4):1387-99. doi: 10.1096/fj.11-197723. Epub 2012 Jan 5.
6
Anti-apoptotic role of caspase-cleaved GAB1 adaptor protein in hepatocyte growth factor/scatter factor-MET receptor protein signaling.半胱氨酸天冬氨酸蛋白酶剪切的 GAB1 衔接蛋白在肝细胞生长因子/分散因子-MET 受体蛋白信号中的抗凋亡作用。
J Biol Chem. 2012 Oct 12;287(42):35382-35396. doi: 10.1074/jbc.M112.409797. Epub 2012 Aug 22.
7
The MET receptor tyrosine kinase in invasion and metastasis.MET受体酪氨酸激酶在侵袭和转移中的作用
J Cell Physiol. 2007 Nov;213(2):316-25. doi: 10.1002/jcp.21183.
8
Signalling by HGF/SF and Met: the role of heparan sulphate co-receptors.肝细胞生长因子/散射因子(HGF/SF)与间质-上皮转化因子(Met)的信号传导:硫酸乙酰肝素共受体的作用
Biochem Soc Trans. 2006 Jun;34(Pt 3):414-7. doi: 10.1042/BST0340414.
9
The shadow of death on the MET tyrosine kinase receptor.死亡阴影笼罩在MET酪氨酸激酶受体上。
Cell Death Differ. 2008 Mar;15(3):427-34. doi: 10.1038/sj.cdd.4402229. Epub 2007 Oct 5.
10
Shedding-generated Met receptor fragments can be routed to either the proteasomal or the lysosomal degradation pathway.产生的 Shedding 受体片段可以被定向到蛋白酶体或溶酶体降解途径。
Traffic. 2012 Sep;13(9):1261-72. doi: 10.1111/j.1600-0854.2012.01384.x. Epub 2012 Jun 20.

引用本文的文献

1
Molecular roles in membrane receptor signaling pathways and cascade reactions in chondrocytes: a review.软骨细胞中膜受体信号通路和级联反应的分子作用:综述
J Mol Histol. 2025 Feb 23;56(2):94. doi: 10.1007/s10735-025-10368-9.
2
Repurposing of c-MET Inhibitor Tivantinib Inhibits Pediatric Neuroblastoma Cellular Growth.c-MET抑制剂替凡替尼的重新利用可抑制小儿神经母细胞瘤细胞生长。
Pharmaceuticals (Basel). 2024 Oct 9;17(10):1350. doi: 10.3390/ph17101350.
3
Tigilanol Tiglate-Induced Changes in Secretome Profiles Alter C-Met Phosphorylation and Cell Surface Protein Expression in H357 Head and Neck Cancer Cells.

本文引用的文献

1
The Proto-oncogene c-Kit Inhibits Tumor Growth by Behaving as a Dependence Receptor.原癌基因 c-Kit 通过作为一种依赖受体抑制肿瘤生长。
Mol Cell. 2018 Nov 1;72(3):413-425.e5. doi: 10.1016/j.molcel.2018.08.040. Epub 2018 Oct 4.
2
Gamma-secretase-dependent signaling of receptor tyrosine kinases.γ-分泌酶依赖性受体酪氨酸激酶信号转导。
Oncogene. 2019 Jan;38(2):151-163. doi: 10.1038/s41388-018-0465-z. Epub 2018 Aug 30.
3
Dependence receptors - the dark side awakens.依赖受体——黑暗面觉醒。
替吉奥醇替吉奥诱导的分泌组谱变化改变了 H357 头颈癌细胞中 C-Met 的磷酸化和细胞表面蛋白表达。
Cells. 2024 Jun 5;13(11):982. doi: 10.3390/cells13110982.
4
Recording and classifying MET receptor mutations in cancers.记录和分类癌症中的MET受体突变。
Elife. 2024 Apr 23;13:e92762. doi: 10.7554/eLife.92762.
5
Loss of LGR5 through Therapy-induced Downregulation or Gene Ablation Is Associated with Resistance and Enhanced MET-STAT3 Signaling in Colorectal Cancer Cells.通过治疗诱导的下调或基因敲除导致 LGR5 丢失与结直肠癌细胞的耐药性和增强的 MET-STAT3 信号有关。
Mol Cancer Ther. 2023 May 4;22(5):667-678. doi: 10.1158/1535-7163.MCT-22-0415.
6
The Occurrence of MET Ectodomain Shedding in Oral Cancer and Its Potential Impact on the Use of Targeted Therapies.MET外显子脱落现象在口腔癌中的发生及其对靶向治疗应用的潜在影响。
Cancers (Basel). 2022 Mar 15;14(6):1491. doi: 10.3390/cancers14061491.
7
Dependence receptors: new targets for cancer therapy.依赖受体:癌症治疗的新靶点。
EMBO Mol Med. 2021 Nov 8;13(11):e14495. doi: 10.15252/emmm.202114495. Epub 2021 Sep 20.
8
Tyrosine Kinase Receptors in Oncology.肿瘤学中的酪氨酸激酶受体。
Int J Mol Sci. 2020 Nov 12;21(22):8529. doi: 10.3390/ijms21228529.
9
Analysis of erythrocyte signalling pathways during Plasmodium falciparum infection identifies targets for host-directed antimalarial intervention.疟原虫感染过程中红细胞信号通路分析鉴定出以宿主为导向的抗疟干预靶点。
Nat Commun. 2020 Aug 11;11(1):4015. doi: 10.1038/s41467-020-17829-7.
FEBS J. 2018 Nov;285(21):3909-3924. doi: 10.1111/febs.14507. Epub 2018 May 31.
4
Hey1- and p53-dependent TrkC proapoptotic activity controls neuroblastoma growth.Hey1 和 p53 依赖性 TrkC 促凋亡活性控制神经母细胞瘤生长。
PLoS Biol. 2018 May 11;16(5):e2002912. doi: 10.1371/journal.pbio.2002912. eCollection 2018 May.
5
Targeting the MET oncogene by concomitant inhibition of receptor and ligand via an antibody-"decoy" strategy.通过抗体“诱饵”策略同时抑制受体和配体来靶向 MET 癌基因。
Int J Cancer. 2018 Oct 1;143(7):1774-1785. doi: 10.1002/ijc.31550. Epub 2018 May 10.
6
The multiple paths towards MET receptor addiction in cancer.癌症中 MET 受体成瘾的多种途径。
Oncogene. 2018 Jun;37(24):3200-3215. doi: 10.1038/s41388-018-0185-4. Epub 2018 Mar 19.
7
Outcome of EGFR-mutated NSCLC patients with MET-driven resistance to EGFR tyrosine kinase inhibitors.表皮生长因子受体(EGFR)突变的非小细胞肺癌(NSCLC)患者对EGFR酪氨酸激酶抑制剂产生MET介导耐药后的转归
Oncotarget. 2017 Oct 9;8(62):105103-105114. doi: 10.18632/oncotarget.21707. eCollection 2017 Dec 1.
8
Bik reduces hyperplastic cells by increasing Bak and activating DAPk1 to juxtapose ER and mitochondria.Bik通过增加Bak和激活DAPk1使内质网(ER)与线粒体并列,从而减少增生细胞。
Nat Commun. 2017 Oct 6;8(1):803. doi: 10.1038/s41467-017-00975-w.
9
Notch Signaling in Development, Tissue Homeostasis, and Disease.Notch 信号通路在发育、组织稳态和疾病中的作用。
Physiol Rev. 2017 Oct 1;97(4):1235-1294. doi: 10.1152/physrev.00005.2017.
10
Exon 14 Deleted MET Receptor as a New Biomarker and Target in Cancers.外显子 14 缺失的 MET 受体作为癌症的新生物标志物和靶点。
J Natl Cancer Inst. 2017 May 1;109(5). doi: 10.1093/jnci/djw262.